Lauren Sabella
Chief Operating Officer chez MANNKIND CORPORATION
Fortune : 1 M $ au 31/03/2024
Profil
Lauren M.
Sabella is the founder of Tugboat Consulting Group, which was founded in 2009.
She is currently the Chief Operating Officer & Executive Vice President at MannKind Corp.
since 2023.
Ms. Sabella's former positions include Chief Operating Officer at Acorda Therapeutics, Inc. from 2021 to 2022, Vice President-Commercial Development at Altus Pharmaceuticals, Inc. from 2006 to 2008, and Vice President-Sales-Eastern Zone at Boehringer Ingelheim Pharmaceuticals, Inc. from 2002 to 2006.
Ms. Sabella received an undergraduate degree from Hofstra University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MANNKIND CORPORATION
0,09% | 27/03/2024 | 246 351 ( 0,09% ) | 1 M $ | 31/03/2024 |
| 24/04/2023 | 536 ( 0,04% ) | 7 081 $ | 31/03/2024 |
Postes actifs de Lauren Sabella
| Sociétés | Poste | Début |
|---|---|---|
| MANNKIND CORPORATION | Chief Operating Officer | 27/03/2023 |
Anciens postes connus de Lauren Sabella
| Sociétés | Poste | Fin |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | Chief Operating Officer | 30/09/2022 |
| Tugboat Consulting Group | Founder | 01/02/2010 |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 30/09/2008 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Sales & Marketing | 01/04/2006 |
Formation de Lauren Sabella
| Hofstra University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ACORDA THERAPEUTICS, INC. | Health Technology |
| MANNKIND CORPORATION | Health Technology |
| Entreprise privées | 3 |
|---|---|
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
| Tugboat Consulting Group |
